Tew, William

Publications

Sort by

Co-Author Network

selected publications

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of gynecologic oncology. 2020 Academic Article GET IT
Times cited: 23
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. Cancer. 2019 Academic Article GET IT
Times cited: 48
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2018 Academic Article GET IT
Times cited: 7
Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecologic oncology. 2017 Information Resource GET IT
Times cited: 21
Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 35
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 60
Association between renal function and chemotherapy-related toxicity in older adults with cancer. Journal of geriatric oncology. 2016 Academic Article GET IT
Times cited: 26
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy. Cancer. 2016 Academic Article GET IT
Times cited: 151
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 211
Ovarian cancer in the older woman. Journal of geriatric oncology. 2016 Information Resource GET IT
Times cited: 40
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 44
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 472
Reply to N. Lowy et al and to J. Dhanda et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Article GET IT
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Academic Article GET IT
Times cited: 9
Is It Time to Centralize Ovarian Cancer Care in the United States?. Annals of surgical oncology. 2015 Review GET IT
Times cited: 47
Anemia and Functional Disability in Older Adults With Cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Academic Article GET IT
Times cited: 20
Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer. Annals of surgery. 2015 Academic Article GET IT
Times cited: 67
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors. Journal of geriatric oncology. 2015 Academic Article GET IT
Times cited: 44
Epithelial ovarian cancer in older women: defining the best management approach. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2015 Information Resource GET IT
Times cited: 2
Treatment of ovarian cancer in the older woman. Gynecologic oncology. 2014 Information Resource GET IT
Times cited: 27
Breast and ovarian cancer in the older woman. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Information Resource GET IT
Times cited: 42
The relationship between age, anxiety, and depression in older adults with cancer. Psycho-oncology. 2014 Academic Article GET IT
Times cited: 104
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. Journal of the American Geriatrics Society. 2014 Academic Article GET IT
Times cited: 114
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 84
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2013 Academic Article GET IT
Times cited: 8
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2013 Academic Article GET IT
Times cited: 72
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 30
Toxicity of bevacizumab in combination with chemotherapy in older patients. The oncologist. 2013 Academic Article GET IT
Times cited: 38
Considerations regarding the administration of systemic therapy for elderly patients with ovarian cancer. Current treatment options in oncology. 2013 Academic Article GET IT
Times cited: 4
Treatment and trials: ovarian cancer in older women. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013 Information Resource GET IT
Times cited: 10
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 33
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 172
Doublet chemotherapy in the elderly patient with ovarian cancer. The oncologist. 2012 Academic Article GET IT
Times cited: 14
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. European journal of cancer. 2012 Academic Article GET IT
Times cited: 31
Intraperitoneal chemotherapy in older women with epithelial ovarian cancer. Journal of Geriatric Oncology. 2012 Article GET IT
Use of complementary medications among older adults with cancer. Cancer. 2012 Academic Article GET IT
Times cited: 25
Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 42
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors. Investigational new drugs. 2011 Academic Article GET IT
Times cited: 7
Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study. Cancer. 2011 Academic Article GET IT
Times cited: 19
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 295
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 134
Consolidation strategies in ovarian cancer: observations for future clinical trials. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 10
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 92
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 32
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 226
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 44
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. The oncologist. 2009 Academic Article GET IT
Times cited: 47
Distress in older patients with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 106
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 165
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Investigational new drugs. 2008 Academic Article GET IT
Times cited: 4
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 37
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 102
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 63
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission. European journal of gynaecological oncology. 2008 Academic Article GET IT
Times cited: 16
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. Journal of the American Geriatrics Society. 2007 Academic Article GET IT
Times cited: 119
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 115
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 58
Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 50
Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 50
Targeted therapies for esophageal cancer. The oncologist. 2005 Information Resource GET IT
Times cited: 134

more ...

less ...

Background

education and training

M.D., University of Rochester School of Medicine and Dentistry 1999
B.S., Boston University 1993

Contact

full name

William Tew

VIVO Weill Cornell Medical College

William Tew Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name